FK506 and rapamycin: differential sensitivity of human, baboon, cynomolgus monkey, dog and pig lymphocytes
- 1 January 1992
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 5, S514-S515
- https://doi.org/10.1111/tri.1992.5.s1.514
Abstract
It has recently been suggested that there are species differences in the sensitivity of T lymphocytes to the immunosuppressive effect of FK506 [3]. We explore this phenomenon further and compare FK506 with rapamycin in lymphocytes from dog, pig, baboon, cynomolgus monkey and man. We fond that the relative sensitivity of T cells to FK506 did not necessarily correlate with their sensitivity to rapamycin, further emphasising the different mode of action of each drug. The serum may alter results of dose‐response curves, and thus autologous serum may introduce an uncontrolled variable when different species are being compared in vitro. We conclude that the differences in sensitivity of lymphocytes from various species to FK506 and rapamycin are independent of each other, and these differences are likely to reflect variation in the overall interactive pathways involved in T‐cell mitogenesis.Keywords
This publication has 5 references indexed in Scilit:
- EVIDENCE THAT FK506 AND RAPAMYCIN BLOCK T CELL ACTIVATION AT DIFFERENT SITES RELATIVE TO EARLY REVERSIBLE PHOSPHORYLATION INVOLVING THE PROTEIN PHOSPHATASES PP1 AND PP2ATransplantation, 1991
- SPECIES DIFFERENCES IN SENSITIVITY OF T LYMPHOCYTES TO IMMUNOSUPPRESSIVE EFFECTS OF FK 506Transplantation, 1990
- The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.The Journal of Immunology, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Contingent Genetic Regulatory Events in T Lymphocyte ActivationScience, 1989